BridgeMD
New treatment option for Spinal Anesthesia
Official title Evaluating the Effect of Intravenous Dexamethasone on the Duration of Spinal Anesthesia After Cesarean Delivery
ClinicalTrials.gov ID: NCT05731960
What this study is testing
What is Dexamethasone?
Dexamethasone is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for spinal anesthesia.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- The goal of this clinical trial is to determine the effects of intravenous (IV) dexamethasone on spinal anesthesia in healthy women having an elective Cesarean delivery (CD) at the IWK Health Centre. The main questions it aims to answer are: 1.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only
You may be able to join if
- Non-emergent Caesarean Delivery with planned spinal anesthesia
- American Society of Anesthesia physical status class \< III
- Age ≥18 years
- Term gestational age (≥37weeks)
- Singleton pregnancy
You likely can't join if
- Obesity (BMI ≥ 45kg/m2)
- Height \< 5'0"
- Patients with significant obstetric or neonatal co-morbidities (i.e., severe maternal cardiac disease, preeclampsia, fetal anomalies)
- Opioid tolerance or sensitivity
- Intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
- Contraindication to neuraxial analgesia (i.e., coagulopathy, infection, neuropathy)
See the full eligibility criteria
- Non-emergent Caesarean Delivery with planned spinal anesthesia
- American Society of Anesthesia physical status class \< III
- Age ≥18 years
- Term gestational age (≥37weeks)
- Singleton pregnancy
- Moderate English language fluency
- Obesity (BMI ≥ 45kg/m2)
- Height \< 5'0"
- Patients with significant obstetric or neonatal co-morbidities (i.e., severe maternal cardiac disease, preeclampsia, fetal anomalies)
- Opioid tolerance or sensitivity
- Intolerance to non-steroidal anti-inflammatory drugs (NSAIDs)
- Contraindication to neuraxial analgesia (i.e., coagulopathy, infection, neuropathy)
- Abnormal spinal anatomy (i.e., severe scoliosis, spina bifida, spinal instrumentation)
- Use of chronic steroids
- A physical or psychiatric condition which impairs cooperation
The study team makes the final eligibility decision.
Where it's taking place
- Halifax, Nova Scotia, Canada
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Halifax, Nova Scotia, Canada. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.